You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Introducing Seretide

Seretide is an inhaled corticosteroid and bronchodilator maintenance treatment for patients with asthma: 12

  • where use of a combination product is appropriate 
  • who require bronchodilator therapy more than twice a week

Learn More

Learn more about Seretide

Salmeterol/fluticasone propionate

Click above to access the Nigerian Thoracic Society guidelines for asthma management in Nigeria.

References:

  1. Seretide Diskus International Prescribing Information version GDS35/IPI20 April 2018.
  2. Seretide Evohaler International Prescribing Information version GDS35/IPI19. April 2018.
  3. Bateman et al 2004 AJRCCM 170: 836 (v1.0).

Seretide is a trademark of the GSK group of companies
For Safety Information on GSK Products, please contact the toll free line 0800 2255 475 (Nigeria) or send an email.